Signaling from RAS to RAF: The Molecules and Their Mechanisms

被引:6
|
作者
Jeon, Hyesung [1 ,2 ]
Tkacik, Emre [1 ,3 ]
Eck, Michael J. [1 ,2 ]
机构
[1] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[2] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[3] Harvard Med Sch, Syst Synthet & Quantitat Biol PhD Program, Boston, MA USA
基金
美国国家卫生研究院;
关键词
MAP kinase pathway; RAS/RAF; protein structure; signal transduction; cancer; RASopathies; PROTEIN PHOSPHATASE 2A; NOONAN-LIKE-SYNDROME; KSR-1 GENE ENCODES; B-RAF; C-RAF; CRYSTAL-STRUCTURE; KINASE-ACTIVITY; MEK INHIBITION; TARGETING RAF; WILD-TYPE;
D O I
10.1146/annurev-biochem-052521-040754
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RAF family protein kinases are a key node in the RAS/RAF/MAP kinase pathway, the signaling cascade that controls cellular proliferation, differentiation, and survival in response to engagement of growth factor receptors on the cell surface. Over the past few years, structural and biochemical studies have provided new understanding of RAF autoregulation,RAF activation by RAS and the SHOC2 phosphatase complex, and RAF engagement with HSP90-CDC37 chaperone complexes. These studies have important implications for pharmacologic targeting of the pathway. They reveal RAF in distinct regulatory states and show that the functional RAF switch is an integrated complex of RAF with its substrate (MEK) and a 14-3-3 dimer. Here we review these advances, placing them in the context of decades of investigation of RAF regulation. We explore the insights they provide into aberrant activation of the pathway in cancer and RASopathies (developmental syndromes caused by germline mutations in components of the pathway).
引用
收藏
页码:289 / 316
页数:28
相关论文
共 50 条
  • [21] Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
    Degirmenci, Ufuk
    Wang, Mei
    Hu, Jiancheng
    CELLS, 2020, 9 (01)
  • [22] Mechanisms of Ras Membrane Organization and Signaling: Ras Rocks Again
    Abankwa, Daniel
    Gorfe, Alemayehu A.
    BIOMOLECULES, 2020, 10 (11) : 1 - 18
  • [23] Molecular mechanisms that regulate Raf kinase signaling.
    Morrison, Deborah
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 23 - 23
  • [24] Selection and characterisation of affibody molecules inhibiting the interaction between Ras and Raf in vitro
    Grimm, Sebastian
    Lundberg, Emma
    Yu, Feifan
    Shibasaki, Seiji
    Vernet, Erik
    Skogs, Marie
    Nygren, Per-Ake
    Graslund, Torbjorn
    NEW BIOTECHNOLOGY, 2010, 27 (06) : 766 - 773
  • [25] Prohibitin is required for Ras-Raf-MAPK signaling and epithelial cell migration
    Rajalingam, K
    Wunder, C
    Brinkmann, V
    Churin, Y
    Oswald, M
    Rapp, UF
    Rudel, T
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2005, 84 : 35 - 35
  • [26] Ras signaling: PP2A puts Ksr and Raf in the right place
    Raabe, T
    Rapp, UR
    CURRENT BIOLOGY, 2003, 13 (16) : R635 - R637
  • [27] Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development
    Eva Chung
    Motonari Kondo
    Immunologic Research, 2011, 49 : 248 - 268
  • [28] Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development
    Chung, Eva
    Kondo, Motonari
    IMMUNOLOGIC RESEARCH, 2011, 49 (1-3) : 248 - 268
  • [29] microRNA-340 as a modulator of RAS-RAF-MAPK signaling in melanoma
    Strong, Ashley M. Poenitzsch
    Setaluri, Vijayasaradhi
    Spiegelman, Vladimir S.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2014, 563 : 118 - 124
  • [30] Regulation of caveolin-1 by RAS/RAF oncogenic signaling in cancer cells
    Aceituno, Veronica Castro
    Cui, Tiantian
    Feng, Haihua
    Yang, Linlin
    Nair, Sindhu
    Williams, Terence M.
    CANCER RESEARCH, 2024, 84 (06)